Celularity Inc.
Celularity Inc. (CELU) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CELU · as of Jun 8, 2026
Key Statistics
Explore Celularity Inc. Data
celu stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 50.0%
The CELU analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $3.00, representing +269.50% upside from the current price of $0.81.
Competitors & Peers
celu competitorsCELU
ANVS
ATNM
BCAB
BTAI
FGENStock Performance
Full HistoryAbout Celularity Inc.
Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments …
what is celularity inc. · celu stock overview · celularity inc. company profile · who is celularity inc. ceo · celu NASDAQ · celularity inc. headquarters · celularity inc. business segments
About Stock Overview & Key Data
Celularity Inc. (CELU) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 8, 2019. As of the latest trading session, CELU stock price is $0.81, with a market capitalization of $19.5M. The stock has returned -58.99% over the past 12 months and -26.86% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Celularity Inc. stock is Buy, with an average 12-month price target of $3.00. In fiscal year 2025, Celularity Inc. reported revenue of $26.6M and net income of -$91.8M. For detailed data — including Celularity Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Celularity Inc. (CELU) stock price is $0.81. The stock is traded on NASDAQ under the ticker symbol CELU. The 52-week range is $0.71 – $4.35.